Skip to main content
. 2022 Sep 5;12:980564. doi: 10.3389/fonc.2022.980564

Table 3.

Survival comparison of the three groups.

1 year survival rate 3 year survival rate 5 year survival rate
OS PFS OS PFS OS PFS
ccRCC 87.7% 73.4% 70.0% 48.0% 56.0% 37.7%
pRCC 75.9% 58.6% 43.8% 41.1% 33.5% 28.0%
other 73.0% 56.6% 58.2% 44.8% 33.3% 27.3%

ccRCC, clear cell renal cell carcinoma; pRCC, papillary renal cell carcinoma; OS, overall survival; PFS, progression free survival.